CEO Adrian Rawcliffe sold $56K of Adaptimmune Therapeutics Plc

Sold$56,009

$5.67Price

9,879Shares

−42%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Tue, Jan 19. Filed Tue, Jan 19, 4:00 PM ET, after the close. Not investment advice.